JUST RELEASED - Transplantation Direct - July 2025 Issue

The July issue of Transplantation Direct covers a wide spectrum of topics in transplantation research. Starting with kidney transplantation, we have studies on policy change effects related to the use of KDPI HCV NAT+ organs, surgical innovations in living organ donation, and the impact of cardiac revascularization on transplant outcomes. In liver transplantation, researchers address whether machine perfusion reduces biliary complications after DCD, and a survey measures current perceptions by surgeons regarding machine perfusion methods; also, there are reports on bioinformatics approaches to assess autophagy in ischemia reperfusion injury, on determining whether high-experience centers have better outcomes in cholangiocarcinoma patients, and on specific surgical techniques to successfully do liver transplants in non-human primates. For the lung transplant community, we have articles looking at the impact of Composite Allocation Score on waitlisting and outcomes, and there is report on analysis of molecular allograft injury profiling in different types of post-transplant lung pathologies. Small bowel transplantation is also covered, with articles on the use of 3D laparoscopic live donor ileal resection with living donation, and new approaches to improving survival in pediatric patients developing GvHD. In kidney-pancreas transplantation, eculizumab plus basiliximab/belatacept is used without CNIs to manage cases of thrombotic microangiopathy. On organ donation, we have a UK study examining eligible DBD donors proceeding via the DCD pathway. Finally, in general, the current landscape of global transplant research collaborations is investigated and summarized. Please visit our open access Transplantation Direct website for all the details on these and other publications.

CLICK HERE TO ACCESS THIS ISSUE

TTS MEMBERS - CLICK HERE TO SIGN-IN FOR OPEN ACCESS THROUGH TTS.ORG


Quick Question: Are You Coming to WTC 2025?

Countdown is on to WTC 2025

Get Ready

Start planning now and get ready to connect, explore, and discover what WTC 2025 has in store! Click here for more.

Discover and Register

Explore world-class speakers and witness groundbreaking advancements. See what makes WTC 2025 truly special here.

WTC 2025: A Congress Unlike Any Other

It’s not too late to register — and if you’re planning to attend, now’s the time to start preparing. With thousands of transplant professionals from around the world coming together, WTC 2025 will be a landmark event you won’t want to miss. Whether you’re booking your flight, submitting an abstract, or finalizing your schedule — the countdown is on.

Join us in San Francisco and be part of something extraordinary.

FOCiS 2025 - 25th Annual Meeting of the Federation of Clinical Immunology Societies

Highlights from the joint TTS-ASHI-AST symposium

The joint TTS-ASHI-AST symposium, held on 24 June 2025 at FOCIS in Boston, drew an engaged audience of around 40 delegates for a lively three-hour exploration of “Evolving Cell Therapies in Transplantation – Epigenetic Modulation.” The programme traced the field’s rapid progress from basic transcriptional control of regulatory T-cells through to clinically relevant biomarkers and precision gene-editing strategies. Highlights included Andrew Wells’ demonstration that Foxp3 relies on Ikaros to safeguard Treg identity, Anita Chong’s assessment of the hurdles facing CAR-Tregs in promoting infectious tolerance, and Joanna Schaenman’s unveiling of an epigenetic CMV-risk score for lung-transplant recipients.

After a welcome coffee break, Sean Agbor-Enoh showed how tissue-of-origin signatures in cell-free DNA can sharpen graft-versus-host diagnostics, John Greenland mapped DNA-methylation fingerprints of allograft injury, and Dimitrios Wagner closed the morning by showcasing CD3ε editing, in contrast to CAR insertion, to retarget Tregs. The steady discussion, cross-disciplinary networking and clear translational focus confirmed the session’s success and underscored the value of partnership between the three societies in driving next-generation cellular therapies towards the clinic.


- (from left to right) Session speakers and moderators: Johnathan Maltzman, Dimitrios Laurin Wagner, Anita Chong, Andrew Wells, Joanna Schaenman, Sean Agbor-Enoh, John Greenland, and Elaine Reed

Transplantation Journal Highlights

Transplantation Journal - Social Media Content

Insights From Refusal Patterns for Deceased Donor Kidney Offers
The likelihood that a deceased donor kidney will be used evolves during the allocation process. Transplant centers can either decline an organ offer for a single patient or for multiple patients at the same time. We hypothesize that refusals for a single patient indicate issues with individual patients, whereas simultaneous refusals for multiple patients indicate issues with organ quality.
Comprehensive Analysis of Lysine β-Hydroxybutyrylation Modification in Ischemia–Reperfusion Injury in Mouse Heart Transplantation
Ischemia–reperfusion (I/R) is an inevitable adverse outcome after heart transplantation, ultimately leading to graft dysfunction and affecting patient survival. Lysine β-hydroxybutyrylation (Kbhb) is a newly identified form of posttranslational modification that has been shown to be correlated with several cardiovascular diseases. This research sought to analyze the changes in Kbhb protein expression in myocardial tissues of mice with cold ischemia and reperfusion of the heart and to investigate its potential mechanisms.

Transplantation Direct - Social Media Content

Bridging the Gap: The State of Global Transplant Research Collaboration
The field of transplant research has long been recognized for its innovative approaches and international collaborations. This study aims to dissect the landscape of global collaborations within transplant research during a past decade.
Soluble DNA Concentration in the Perfusate is a Predictor of Posttransplant Renal Function in Hypothermic Machine Perfused Kidney Allografts
Hypothermic machine perfusion (HMP) has greatly improved kidney allograft preservation. However, tissue damage still occurs during HMP, affecting posttransplant graft function. Therefore, better methods are needed to continuously assess organ quality and to predict posttransplant graft function and survival. We propose that soluble DNA (sDNA) concentration in HMP perfusate can be used as a noninvasive biomarker for this purpose.

ITS 2025 - Early-bird Registration is Open

Join us for the 2025 International Transplantation Science meeting (ITS 2025) and connect with the leading global transplantation community!

On behalf of AST, ESOT and TTS, we wish to extend to you a warm welcome to the 2025 International Transplant Science meeting in San Diego, California USA.


In the News

Image credit: Vertex

London woman off insulin for Type 1 diabetes after a single dose of experimental manufactured stem cells

Amanda Smith celebrates the day, August 1, nearly two years ago, when she stopped taking insulin to manage her type one diabetes, just a few months after getting a dose of experimental stem cells as part of a study.

Social

Contact

Staff Directory
+1-514-874-1717
info@tts.org

Address

The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada